Insulet Corporation

Insulet Corporation

PODD·NASDAQ

$146.41

+2.2%
HealthcareMedical - Devices

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

At a Glance

Live Snapshot
Market Cap$10.14B
EPS3.5100
P/E Ratio41.71
Earnings Date08/06/2026

podd

Shares Outstanding

Last Annual Value

71.89M

3-Year CAGR

1%

5-Year CAGR

2%

10-Year CAGR

2%

Insulet Corporation

Insulet Corporation Competitors Analysis of shares-outstanding

PODD · NASDAQ
Companyshares-outstanding
CAGR 3Y
CAGR 5Y
CAGR 10Y
71.89M
-0.8%0.9%2.3% 
198.70M
-1.8%-1.1%-0.2%
STE logo
STERIS plc
NYSE:STE
98.70M
-0.5%2.8%3.3%
BIIB logo
Biogen Inc.
NASDAQ:BIIB
146.70M
0.3%-0.4%-3.9%
72.70M
-1.2%-1.0%-0.3%
83.80M
-1.5%-3.0%-2.2%
113.00M
0.0%-2.5%-2.3%
59.71M
0.2%-0.8%-3.1%
DXCM logo
DexCom, Inc.
NASDAQ:DXCM
405.50M
-1.6%-1.1%1.9%
Insulet Corporation

Insulet Corporation Fair Value Envelope

PODD · NASDAQ

Our analysis suggests that PODD has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $146.41, this represents a potential HIDDEN relative to our calculated worth for Insulet Corporation.

Intrinsic Value
Current Price: $146.41